Chidamide Plus R-CHOP Approved in China for MYC/BCL2–

Chidamide plus R-CHOP has received approval from China’s NMPA for the management of diffuse large B-cell lymphoma.

Related Keywords

Japan , Taiwan , China , Chipscreen Biosciences , Xianping Lu , China National Medical Products Administration , Lymphoma International Prognosis Index , Data Monitoring Committee , National Medical Products Administration , Independent Data Monitoring Committee , Lugano Classification , Diffuse Largeb Cell Lymphoma , Chidamide , R Chop ,